Showing results (141-150 of 377) with videos related to

Sort By:
Pageof 38
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2018
Gut Dysbiosis Associated With Hepatitis C Virus InfectionTakako Inoue, Jiro Nakayama, Kei Moriya, et al.
Current Drug Abuse Reviews|July 28, 2009
Potential role of ADAMTS13 in the progression of alcoholic hepatitisMasahito Uemura, Yoshihiro Fujimura, Tomomi Matsuyama, et al.
Hepatology (Baltimore, Md.)|February 26, 2003
Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosisTsutomu Masaki, Yasushi Shiratori, William Rengifo, et al.
International Journal of Oncology|September 18, 2004
Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC ratsShuhei Yoshida, Tsutomu Masaki, Han Feng, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Intrahepatic cholangiocarcinoma associated with central calcification and arterio-portal shuntMitsuteru Kitade, Hitoshi Yoshiji, Junichi Yamao, et al.
International Journal of Oncology|July 13, 2005
Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle moleculesShigeki Kuriyama, Misuzu Hitomi, Hitoshi Yoshiji, et al.
International Journal of Oncology|March 9, 2005
Enhanced expression of p46 Shc in the nucleus and p52 Shc in the cytoplasm of human gastric cancerSatoko Yukimasa, Tsutomu Masaki, Shuhei Yoshida, et al.
BMC Gastroenterology|July 9, 2021
Small intestinal follicular lymphoma induced by methotrexate: a case reportYui Osaki, Hideto Kawaratani, Hiroki Kachi, et al.
World Journal of Gastroenterology|January 9, 2018
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversityKosuke Kaji, Hiroaki Takaya, Soichiro Saikawa, et al.
Pageof 38